{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:35:48Z","timestamp":1785458148429,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ebiom.2024.105437","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T19:27:16Z","timestamp":1731353236000},"page":"105437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity"],"prefix":"10.1016","volume":"110","author":[{"given":"Yuhan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanbo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2024.105437_bib1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J\u00a0Med Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105437_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105437_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105437_bib4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105437_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3389\/fimmu.2022.857440","article-title":"A\u00a0capsid virus-like particle-based SARS-CoV-2 vaccine induces high levels of antibodies and protects rhesus macaques","volume":"13","author":"Volkmann","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105437_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003769","article-title":"Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: a phase 2 randomized placebo-controlled trial","volume":"18","author":"Formica","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41467-020-20251-8","article-title":"Capsid-like particles decorated with the SARSCoV-2 receptor-binding domain elicit strong virus neutralization activity","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/vaccines8010139","article-title":"Recent progress on the versatility of virus-like particles","volume":"8","author":"Qian","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ebiom.2024.105437_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.790121","article-title":"Virus-like particles: revolutionary platforms for developing vaccines against emerging infectious diseases","volume":"12","author":"Tariq","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2024.105437_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109650","article-title":"A\u00a0perspective on SARS-CoV-2 virus-like particles vaccines","volume":"115","author":"Gao","year":"2023","journal-title":"Int Immunopharm"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105437_bib11","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41422-020-00392-7","article-title":"A\u00a0COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice","volume":"30","author":"Lu","year":"2020","journal-title":"Cell Res"},{"issue":"29","key":"10.1016\/j.ebiom.2024.105437_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305896120","article-title":"Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01492-21","article-title":"Susceptibilities of human ACE2 genetic variants in coronavirus infection","volume":"96","author":"Ren","year":"2022","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib14","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/s41467-023-37926-7","article-title":"Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105437_bib15","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.cell.2021.02.044","article-title":"A\u00a0trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105437_bib16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41596-021-00491-8","article-title":"Engineering SARS-CoV-2 using a reverse genetic system","volume":"16","author":"Xie","year":"2021","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib17","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41467-021-25589-1","article-title":"Sequences in the cytoplasmic tail of SARS-CoV-2 Spike facilitate expression at the cell surface and syncytia formation","volume":"12","author":"Cattin-Ortol\u00e1","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105437_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A\u00a0pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105437_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Global Challenges"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib21","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1038\/s41467-022-34630-w","article-title":"Muscle5: high-accuracy alignment ensembles enable unbiased assessments of sequence homology and phylogeny","volume":"13","author":"Edgar","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105437_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105437_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104971","article-title":"Recent progress on the mutations of SARS-CoV2 spike protein and suggestions for prevention and controlling of the pandemic","volume":"93","author":"Li","year":"2021","journal-title":"Infect Genet Evol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105437_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02979-21","article-title":"The impact of evolving SARS-CoV-2 mutations and variants on COVID-19 vaccines","volume":"13","author":"McLean","year":"2022","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105437_bib25","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"Yeung","year":"2021","journal-title":"Cell"},{"issue":"7852","key":"10.1016\/j.ebiom.2024.105437_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105437_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.689065","article-title":"Generation and effect testing of a SARS-CoV-2 RBD-targeted polyclonal therapeutic antibody based on a 2-D airway organoid screening system","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2024.105437_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105509","article-title":"A\u00a0new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly","volume":"209","author":"Hu","year":"2023","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/v13010109","article-title":"Domains and functions of spike protein in sars-Cov-2 in the context of vaccine design","volume":"13","author":"Xia","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105437_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.201610031","article-title":"Protein sorting at the ER\u2013Golgi interface","volume":"215","author":"Gomez-Navarro","year":"2016","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.ebiom.2024.105437_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-016-0246-3","article-title":"A\u00a0glimpse of the ERM proteins","volume":"23","author":"Ponuwei","year":"2016","journal-title":"J\u00a0Biomed Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105437_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105437_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.chom.2020.11.003","article-title":"Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies","volume":"28","author":"Cortese","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105437_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049566","article-title":"Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage","volume":"7","author":"Millet","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105437_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167280","article-title":"The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation","volume":"434","author":"Rajah","year":"2022","journal-title":"J\u00a0Mol Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105437_bib36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105437_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.tibs.2021.06.001","article-title":"Cell entry by SARS-CoV-2","volume":"46","author":"Peng","year":"2021","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105437_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00002-21","article-title":"SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in their requirements for receptor expression and proteolytic activation","volume":"95","author":"H\u00f6rnich","year":"2021","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib39","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jmv.27339","article-title":"Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry","volume":"94","author":"Li","year":"2022","journal-title":"J\u00a0Med Virol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105437_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrm2866","article-title":"Organizing the cell cortex: the role of ERM proteins","volume":"11","author":"Fehon","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.emboj.7601475","article-title":"Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells","volume":"26","author":"Naghavi","year":"2007","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100902","article-title":"Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell\u2013cell fusion","volume":"297","author":"Barrett","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105437_bib43","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.5812\/ijpr-127042","article-title":"A\u00a0review of virus-like particle-based SARS-CoV-2 vaccines in clinical trial phases","volume":"21","author":"Sharifzadeh","year":"2022","journal-title":"Iranian J Pharm Res"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105437_bib44","first-page":"335","article-title":"Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2","volume":"60","author":"Kim","year":"2022","journal-title":"J\u00a0Microbiol"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105437_bib45","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.cell.2023.04.024","article-title":"ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines","volume":"186","author":"Hoffmann","year":"2023","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105437_bib46","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/v14081603","article-title":"Immune escape associated with RBD Omicron mutations and SARS-CoV-2 evolution dynamics","volume":"14","author":"Kudriavtsev","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105437_bib47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41564-023-01588-4","article-title":"Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants","volume":"9","author":"Reuschl","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2024.105437_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101533","article-title":"Mutations of SARS-CoV-2 spike protein: implications on immune evasion and vaccine-induced immunity","volume":"55","author":"Mengist","year":"2021","journal-title":"Semin Immunol"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105437_bib49","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1039\/c3cp44128h","article-title":"Impact of the virus purification protocol on aggregation and electrokinetics of MS2 phages and corresponding virus-like particles","volume":"15","author":"Dika","year":"2013","journal-title":"Phys Chem Chem Phys"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105437_bib50","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.str.2020.10.001","article-title":"The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET","volume":"28","author":"Liu","year":"2020","journal-title":"Structure"},{"issue":"6499","key":"10.1016\/j.ebiom.2024.105437_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARSCoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:58:06Z","timestamp":1733954286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"alternative-id":["S2352396424004730"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105437","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105437"}}